Discovery of orally active indirubin-3′-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemiaPyeonghwa Jeong, Yoon-Gyoon Kim, Jungil Choi et al.|European Journal of Medicinal Chemistry|2020Cited by 29